EUVIMEDEUVIMED entdecken
Crossref

Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study

Sarah-Louisa Mahi, Siamak Bahram, Jérôme Harambat, Lise Allard, Etienne Merlin, Alexandre Belot, Bruno Ranchin, Julie Tenenbaum, Marie Magnavacca, Lucile Haumesser, Emma Allain-Launay, Christine Pietrement und 9 weitere

Pediatric Nephrology · 2023

DOI: 10.1007/s00467-022-05855-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Nephrology, 2023. Verfasst von Sarah-Louisa Mahi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Service de Pédiatrie 1, CHU University Hospital Hautepierre, 1, Avenue Molière, 67098, Strasbourg, France. Hauptthemen laut MEDLINE: Antibodies, Antineutrophil Cytoplasmic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pediatric ANCA vasculitis is a rare group of diseases with a scarcity of data in children. Annual incidence appeared to increase in the last several years, placing higher interest in the clinical and therapeutical outcomes of the disorder. Also, the growing use of rituximab questions the latest outcomes in these diseases. We therefore conducted a retrospective study to better understand the current characteristics, management, and the latest outcomes of the disorder. METHODS: We conducted a 9-year retrospective study of 46 children in 14 different centers across France to describe their clinical and laboratory presentations, therapeutic regimens, and kidney outcome. RESULTS: P-ANCA appeared to be a potential marker for higher relapse risk. Compared to adults, we found that ear-nose-throat presentations were frequent (45.7%) and more severe. Despite an evolution in the treatment management, kidney outcome remained poor with a substantial proportion of chronic kidney disease (54.8% at 1 year). Mortality stays low with 3 patients (6.5%) deceased at the end of our study. CONCLUSION: Clinical presentation was as previously described and time to diagnosis remains long. P-ANCA is a statistically significant marker for increased relapse risk. We observed a modification in the treatment regimens over the past several years with a growing use of rituximab and a decreasing use of cyclophosphamide. Despite these changes, kidney outcome remains poor and prospective studies should be conducted to assess the most appropriate therapeutic modality for each patient. A higher resolution version of the Graphical abstract is available as Supplementary information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Antineutrophil CytoplasmicAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAdultHumansChildRetrospective StudiesRituximabProspective StudiesRecurrence

Stichwörter der Autor:innen

ANCA-associated vasculitisKidney outcomePediatricRelapse

Substanzen

Antibodies, Antineutrophil CytoplasmicRituximab

Autor:innen und Institutionen

  • Service de Pédiatrie 1, CHU University Hospital Hautepierre, 1, Avenue Molière, 67098, Strasbourg, France.
  • Laboratoire d'Immunologie (HUS), ImmunoRhumatologie Moléculaire (INSERM UMR_S1109), CHU Strasbourg, Strasbourg, France.
  • Service de Néphrologie Pédiatrique, Centre de Référence Maladies Rénales Rares du Sud-Ouest, CHU de Bordeux, Bordeaux, France.
  • Service de Pédiatrie Générale Multidisciplinaire, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Service de Néphrologie-Rhumatologie-Dermatologie Pédiatriques, Hospices Civils de Lyon, Lyon, France.
  • Service de Pédiatrie, CHU Arnaud de Villeneuve, Montpellier, France.

Zitieren

APA

Mahi, S. L., Bahram, S., Harambat, J., Allard, L., Merlin, E., Belot, A., Ranchin, B., Tenenbaum, J., Magnavacca, M., Haumesser, L., Allain-Launay, E., Pietrement, C., Flodrops, H., Ruin, M., Dossier, C., Decramer, S., Ballot-Schmitt, C., Boyer, O. G., Seugé, L., …, & Zaloszyc, A. (2023). Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study. Pediatric Nephrology. https://doi.org/10.1007/s00467-022-05855-0

Vancouver

Mahi SL, Bahram S, Harambat J, Allard L, Merlin E, Belot A, et al. Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study. Pediatric Nephrology. 2023. doi:10.1007/s00467-022-05855-0

BibTeX
@article{Mahi2023,
  author = {Mahi, Sarah-Louisa and Bahram, Siamak and Harambat, Jérôme and Allard, Lise and Merlin, Etienne and Belot, Alexandre and Ranchin, Bruno and Tenenbaum, Julie and Magnavacca, Marie and Haumesser, Lucile and Allain-Launay, Emma and Pietrement, Christine and Flodrops, Hugues and Ruin, Mahe and Dossier, Claire and Decramer, Stéphane and Ballot-Schmitt, Claire and Boyer, Olivia Gillion and Seugé, Laure and Ulinski, Tim and Zaloszyc, Ariane},
  title = {Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study},
  journal = {Pediatric Nephrology},
  year = {2023},
  doi = {10.1007/s00467-022-05855-0}
}
Kostenlos starten →